. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: J Neurovirol. 2016 Jul 11;23(1):113–124. doi: 10.1007/s13365-016-0462-3

Table 1.

Demographics of the Drexel Medicine CNS AIDS Research and Eradication Study (CARES) Cohort. Characteristics for the entire patient cohort (as of September 2015) are provided, as are the corresponding demographics for the 112 patients encompassed by this study. Each parameter is accompanied by a 95% confidence interval (in parentheses). Years seropositive is determined by a review of clinical history information.

	Entire Cohort	Patients in this Study
Age (years)	49 (42-45)	51 (46-56)
Current Drug Use	71.00%	63.00%
Gender	62% Male	64% Male
Latest CD4 T-Cell Count (cells/mm³)	521 (328-793)	641 (428-904)
Latest Viral Load (copies/mL)	48 (22-943)	20 (13-193)
Years on ART	14 (9-18)	14 (9-18)
Years Seropositive	16 (11-22)	19 (14-24)